ATE122399T1 - Klonier- und expressionvektoren in einem aktinomycetenstamm,verfahren zur transformation dises stammes,erhaltener stamm und herstellung von proteinen. - Google Patents

Klonier- und expressionvektoren in einem aktinomycetenstamm,verfahren zur transformation dises stammes,erhaltener stamm und herstellung von proteinen.

Info

Publication number
ATE122399T1
ATE122399T1 AT89401347T AT89401347T ATE122399T1 AT E122399 T1 ATE122399 T1 AT E122399T1 AT 89401347 T AT89401347 T AT 89401347T AT 89401347 T AT89401347 T AT 89401347T AT E122399 T1 ATE122399 T1 AT E122399T1
Authority
AT
Austria
Prior art keywords
strain
cloning
transforming
proteins
production
Prior art date
Application number
AT89401347T
Other languages
English (en)
Inventor
Tamara Smokvina
Frederic Boccard
Michel Guerineau
Original Assignee
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Nat Rech Scient filed Critical Centre Nat Rech Scient
Application granted granted Critical
Publication of ATE122399T1 publication Critical patent/ATE122399T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
AT89401347T 1988-05-18 1989-05-16 Klonier- und expressionvektoren in einem aktinomycetenstamm,verfahren zur transformation dises stammes,erhaltener stamm und herstellung von proteinen. ATE122399T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8806638A FR2631634B1 (fr) 1988-05-18 1988-05-18 Vecteurs de clonage et d'expression dans une souche d'actinomycete, procede de transformation de cette souche, souche d'actynomycete obtenue et preparation de proteines

Publications (1)

Publication Number Publication Date
ATE122399T1 true ATE122399T1 (de) 1995-05-15

Family

ID=9366396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89401347T ATE122399T1 (de) 1988-05-18 1989-05-16 Klonier- und expressionvektoren in einem aktinomycetenstamm,verfahren zur transformation dises stammes,erhaltener stamm und herstellung von proteinen.

Country Status (8)

Country Link
US (1) US5688689A (de)
EP (1) EP0350341B1 (de)
JP (1) JP2913406B2 (de)
AT (1) ATE122399T1 (de)
CA (1) CA1340746C (de)
DE (1) DE68922533T2 (de)
ES (1) ES2073451T3 (de)
FR (1) FR2631634B1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2713658B1 (fr) * 1993-12-08 1996-04-12 Rhone Poulenc Rorer Sa Séquences d'acides nucléiques régulatrices et utilisations.
US6825012B2 (en) 1995-02-23 2004-11-30 Gencell S.A. DNA molecules, preparation and use in gene therapy
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique
US7255989B1 (en) 1999-11-29 2007-08-14 Aventis Pharma S.A. Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds
US6861513B2 (en) 2000-01-12 2005-03-01 Schering Corporation Everninomicin biosynthetic genes
WO2001087936A2 (en) * 2000-05-17 2001-11-22 Schering Corporation Isolation of micromonospora carbonacea var africana pmlp1 integrase and use of integrating function for site-specific integration into micromonospora halophitica and micromonospora carbonacea chromosome
FR2921663A1 (fr) 2007-10-02 2009-04-03 Bluestar Silicones France Soc Polyorganosiloxanes a fonction piperidine depourvus de toxicite par contact cutane et utilisation de ces derniers dans des compositions cosmetiques
DE102011118018B4 (de) 2011-10-25 2017-10-26 Plasmidfactory Gmbh & Co. Kg Minicircles mit Transpositionskassetten und ihre Verwendung zur Transformation von Zellen
DE102013220859B4 (de) 2013-10-15 2016-09-08 Plasmidfactory Gmbh & Co. Kg Minicircles mit viralen Expressionskassetten und ihre Verwendung zur Transformation von Zellen zur Erzeugung rekombinanter Viren oder viraler Genvektoren

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743546A (en) * 1985-02-13 1988-05-10 Biotechnica International, Inc. Controlled gene excision
DE3751631T2 (de) * 1986-02-28 1996-05-02 Smithkline Beecham Corp Das Streptomyces-Gal-Operon
DE3614310A1 (de) * 1986-04-28 1987-10-29 Hoechst Ag Verfahren zur isolierung mutierter gene sowie der entsprechenden wildtyp-gene

Also Published As

Publication number Publication date
DE68922533T2 (de) 1995-10-19
FR2631634A1 (fr) 1989-11-24
DE68922533D1 (de) 1995-06-14
ES2073451T3 (es) 1995-08-16
EP0350341A1 (de) 1990-01-10
JPH0269185A (ja) 1990-03-08
EP0350341B1 (de) 1995-05-10
JP2913406B2 (ja) 1999-06-28
US5688689A (en) 1997-11-18
FR2631634B1 (fr) 1991-06-14
CA1340746C (fr) 1999-09-14

Similar Documents

Publication Publication Date Title
ATE83801T1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
ATE280235T1 (de) Plasmid zur herstellung von crm-protein und diphtherie-toxin
DE68921364D1 (de) Verfahren zur Herstellung von Proteinen mittels rekombinanter DNA.
DE69029657D1 (de) Menschliches cytokin, interleukin-9
DE3586333D1 (de) Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE68928467D1 (de) RNS-Katalysator zur Spaltung von spezifischen RNS-Sequenzen
ATE91716T1 (de) Verfahren zur herstellung vielkettige polypeptide oder proteine.
DE69231137D1 (de) Verfahren zur Herstellung von Peroxidasen in einem Aspergillusstamm
ATE122399T1 (de) Klonier- und expressionvektoren in einem aktinomycetenstamm,verfahren zur transformation dises stammes,erhaltener stamm und herstellung von proteinen.
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
ATE228565T1 (de) Nukleinsäure, expressionsvektor und zusammensetzungen zur identifizierung und herstellung von rekombinanten sialyltransferasen
ATE71658T1 (de) Verfahren zur herstellung von humanlysozym.
ATE334195T1 (de) Proteine mit zellulase-aktivitäten und prozess für ihre herstellung
ATE102994T1 (de) Verfahren zur herstellung von proteinen.
ATE145004T1 (de) Verfahren zur herstellung von luciferase durch rekombinante expression eines luciferase- kodierenden gens
DE69224269D1 (de) Biosynthetisches Verfahren zur Herstellung von Protein
ATE88499T1 (de) Expressionsvektoren zur proteinsynthese sowie plasmidreplikons und sequenzkassetten, die zur herstellung solcher vektoren geeignet sind.
DE69031996D1 (de) Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung
ATE190653T1 (de) Verfahren zur herstellung von rekombinanten und synthetischen peptiden und deren verwendung
DE69132845D1 (de) Verfahren zur Herstellung von Proteinen durch Verwendung von CKS-Fusionsproteinen
ATE80181T1 (de) Zur wirksamen gen-expression faehiger vektor und verwendung desselben.
ATE167897T1 (de) Expressionsvektoren und verfahren zur herstellung intrazellularer proteine
DE3750112D1 (de) DNS-Sequenz mit einer Funktion, die sich ausdrückt durch eine Überproduktion extrazellulärer Proteine in verschiedenen Bazillusstämmen und Vektoren die diese Sequenz enthalten.
EP0195087A4 (de) Zyklische doppelsträngige dns, deren h2rstellung, mikroorganismen, die diese enthalten, verfahren zur herstellung von einer antigen-determinanten stelle des poliovirus-kapsids aufweisenden proteins und protein-vp1 unter verwendung derselben.
DE58909889D1 (de) Verfahren zur Herstellung von Proteinen oder proteinhaltigen Genprodukten

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time